Differing guidelines from FDA & WHO spells adverse global impact

While FDA approves certain categories of safer alternatives based on scientific data, the WHO has a conflicting stance, suggesting they expose legal-age smokers to harmful substances. More recently WHO delayed alerting member countries, leading to COVID-19’s rapid spread. India stood distinguished by taking an independent customized approach to fight the virus at the scale we did.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/NEzA5mQ
via